XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Under the Company's stock option plans, the Board of Directors may grant restricted stock and options to purchase common shares to the Company's employees, officers, directors and consultants. The Company accounts for stock options in accordance with FASB ASC Topic 718, Compensation - Stock Compensation, with stock-based compensation expense recognized over the vesting period based on the fair value on the grant date utilizing the Black Scholes model, which includes a number of estimates that affect the grant date fair value and the amount of expense to recognize.

The Company recognized approximately $1,650,000 in stock-based compensation expense for the three months ended March 31, 2022, as compared with $1,194,000 for the three months ended March 31, 2021.

Stock option activity is summarized as follows:
Number of optionsWeighted average exercise price
Outstanding at December 31, 2021
5,397,691 $5.95 
Granted1,478,419 10.96 
Exercised(65,840)5.96 
Canceled and forfeited(14,526)10.23 
Outstanding at March 31, 2022
6,795,744 $7.03 

The Company allows stock option holders to exercise stock-based awards by surrendering stock-based awards with an intrinsic value equal to the cumulative exercise price of the stock-based awards being exercised, referred to as net settlements. These surrenders are included in stock options exercised in the options rollforward above. For the three months ended March 31, 2022 and 2021, respectively, we received 22,654 and 15,441 options as payment in the exercise of 19,013 and 21,141 options.

Common shares required to be issued upon the exercise of stock options would be issued from authorized and unissued shares. The Company calculated the grant date fair value of options granted in 2022 ("2022 Grants") utilizing a Black Scholes model.
2022 Grants
Strike price$10.96
Risk-free rate1.6%
Expected dividend yield
Expected volatility69.6%
Expected term (in years)6